adenomyosis
Conditions
Interventions
experimental group:bleomycin+UAE treatment
control group:UAE treatment
Sponsors
Chinese PLA General Hospital
Eligibility
Sex/Gender
Male
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Aged from 18 to 60 years; 2. Clinical or pathological diagnosis of adenomyosis; 3. Complete clinical, laboratory and imaging data; 4. Significant clinical symptoms: increased menstrual volume, dysmenorrhea progressive aggravation; 5. There are no other contraindications for angiography (such as contrast agent allergy, uncontrolled infection, uncorrected coagulation disorders, etc); 6. The subjects voluntarily joined the study and signed the informed consent, and were able to cooperate with the follow-up and complete the study.
Exclusion criteria
Exclusion criteria: 1. Abnormal coagulation function (INR > 1.5 or prothrombin time > ULN+4 SEC), bleeding tendency or receiving thrombolytic or anticoagulant therapy; 2. Patients with gynecological malignancy; 3. Active stage of infectious disease; 4. Patients with serious heart, lung, kidney, brain and other basic diseases who cannot tolerate interventional therapy; 5. Pregnancy or lactation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| menstrual blood volume;lesion volume; | — |
Countries
China
Contacts
Public ContactYuan Bing
Chinese PLA General Hospital
Outcome results
None listed